Dr. Lenz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 N 7th St
Bismarck, ND 58501Phone+1 701-323-5422
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2012 - 2015
University of North Dakota School of Medicine and Health SciencesClass of 2012
Certifications & Licensure
ND State Medical License 2021 - 2026
MN State Medical License 2013 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 314 citationsApixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.Robert D. McBane, Waldemar E. Wysokinski, Jennifer Le-Rademacher, Tyler Zemla, Aneel A. Ashrani
Journal of Thrombosis and Haemostasis. 2020-02-01 - 98 citationsApixaban and dalteparin in active malignancy associated venous thromboembolism. The ADAM VTE Trial.Robert D. McBane, Charles L. Loprinzi, Aneel A. Ashrani, Juliana Perez Botero, Roberto A. Leon Ferre
Thrombosis and Haemostasis. 2017-08-24 - 70 citationsRivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical LocationDawid Janczak, Małgorzata Mimier, Robert D. McBane, Patrick S. Kamath, Benjamin Simmons
Mayo Clinic Proceedings. 2018-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
